SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-006941
Filing Date
2021-03-24
Accepted
2021-03-24 07:31:21
Documents
15
Period of Report
2021-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20210312b_8k.htm   iXBRL 8-K 25286
2 EXHIBIT 99.1 ex_233629.htm EX-99.1 87042
7 moleculin-logo_horizresizedf.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-006941.txt   311729

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210324.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210324_def.xml EX-101.DEF 11973
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210324_lab.xml EX-101.LAB 16011
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210324_pre.xml EX-101.PRE 12182
8 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210312b_8k_htm.xml XML 2672
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 21766630
SIC: 2834 Pharmaceutical Preparations